FDA Import Refusal 1FX-8502518-7/20002/1 — CIPLA LIMITED
The FDA refused shipment 1FX-8502518-7/20002/1 from CIPLA LIMITED (India) on Sep 3, 2026. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 75